142 related articles for article (PubMed ID: 10493608)
21. Bacterial growth kinetics of "M. lufu" in the presence and absence of various drugs alone and in combination. A model for the development of combined chemotherapy against M. leprae?
Seydel JK; Wempe EG
Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):20-30. PubMed ID: 7042611
[TBL] [Abstract][Full Text] [Related]
22. The activity of rifabutin against Mycobacterium leprae in armadillos.
Dhople AM; Williams SL
Int J Antimicrob Agents; 1997 Jan; 9(3):169-73. PubMed ID: 9552713
[TBL] [Abstract][Full Text] [Related]
23. In vivo susceptibility of Mycobacterium leprae to sitafloxacin (DU-6859a), either singly or in combination with rifampicin analogues.
Dhople AM; Namba K
Int J Antimicrob Agents; 2003 Mar; 21(3):251-5. PubMed ID: 12636987
[TBL] [Abstract][Full Text] [Related]
24. Dapsone resistance in Mycobacterium leprae.
Gillis TP; Williams DL
Lepr Rev; 2000 Dec; 71 Suppl():S91-5. PubMed ID: 11201896
[TBL] [Abstract][Full Text] [Related]
25. [Drug resistance of Mycobacterium leprae].
Pattyn SR
Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
[No Abstract] [Full Text] [Related]
26. Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae.
Cambau E; Perani E; Guillemin I; Jamet P; Ji B
Lancet; 1997 Jan; 349(9045):103-4. PubMed ID: 8996430
[No Abstract] [Full Text] [Related]
27. Brodimoprim synergy against Enterococcus faecalis evaluated in vitro.
Richards RM; Xing JZ
J Antimicrob Chemother; 1996 Jul; 38(1):27-37. PubMed ID: 8858454
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous detection of Mycobacterium leprae and its susceptibility to dapsone using DNA heteroduplex analysis.
Williams DL; Pittman TL; Gillis TP; Matsuoka M; Kashiwabara Y
J Clin Microbiol; 2001 Jun; 39(6):2083-8. PubMed ID: 11376039
[TBL] [Abstract][Full Text] [Related]
29. The in-vitro activities of novel benzoxazinorifamycins against Mycobacterium leprae.
Dhople AM; Ibanez MA
J Antimicrob Chemother; 1995 Apr; 35(4):463-71. PubMed ID: 7628981
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of action of the folate blocker diaminodiphenylsulfone (dapsone, DDS) studied in E. coli cell-free enzyme extracts in comparison to sulfonamides (SA).
Seydel JK; Richter M; Wempe E
Int J Lepr Other Mycobact Dis; 1980 Mar; 48(1):18-29. PubMed ID: 6988345
[TBL] [Abstract][Full Text] [Related]
31. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
Matsuoka M; Kashiwabara Y; Namisato M
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
[TBL] [Abstract][Full Text] [Related]
32. Mutation analysis of the Mycobacterium leprae folP1 gene and dapsone resistance.
Nakata N; Kai M; Makino M
Antimicrob Agents Chemother; 2011 Feb; 55(2):762-6. PubMed ID: 21115799
[TBL] [Abstract][Full Text] [Related]
33. The effect of rifampicin and dapsone on experimental Mycobacterium leprae infections: minimum inhibitory concentrations and bactericidal action.
Holmes IB; Hilson GR
J Med Microbiol; 1972 May; 5(2):251-61. PubMed ID: 4555734
[No Abstract] [Full Text] [Related]
34. Discovery of a potential lead compound for treating leprosy with dapsone resistance mutation in M. leprae folP1.
Nisha J; Ramanathan K; Nawaz Khan F; Dhanasekaran D; Shanthi V
Mol Biosyst; 2016 Jun; 12(7):2178-88. PubMed ID: 27120972
[TBL] [Abstract][Full Text] [Related]
35. Brodimoprim, a new bacterial dihydrofolate reductase inhibitor: a minireview.
Periti P
J Chemother; 1995 Jun; 7(3):221-3. PubMed ID: 7562018
[TBL] [Abstract][Full Text] [Related]
36. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
Walker LL; Van Landingham RM; Shinnick TM
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
[TBL] [Abstract][Full Text] [Related]
37. Strategies in the development of new drugs and drug combinations against leprosy, demonstrated on the example of folate and gyrase inhibitors.
Seydel JK; Rosenfeld M; Sathish M; Wiese M; Schaper KJ; Hachtel G; Haller R; Kansy M; Dhople AM
Lepr Rev; 1986; 57 Suppl 3():235-53. PubMed ID: 3033412
[No Abstract] [Full Text] [Related]
38. [Diaminodiphenylsulfone resistance of Mycobacterium leprae due to mutations in the dihydropteroate synthase gene].
Kai M
Nihon Hansenbyo Gakkai Zasshi; 2004 Sep; 73(3):221-6. PubMed ID: 15508724
[TBL] [Abstract][Full Text] [Related]
39. The infectivity of drug resistant cases.
Desai AC; Apte SN; Bhide MB
Lepr India; 1977 Jan; 49(1):54-8. PubMed ID: 330944
[TBL] [Abstract][Full Text] [Related]
40. Bacterial growth kinetics of Escherichia coli and mycobacteria in the presence of brodimoprim and metioprim alone and in combination with sulfamerazine and dapsone (VI).
Seydel JK; Wempe EG; Rosenfeld M
Chemotherapy; 1983; 29(4):249-61. PubMed ID: 6347548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
